The Efficacy and Safety of Female PRP Co-incubation With Sperm During (IUI) Cycles

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-42
SponsorChinese University of Hong Kong

About this trial

The investigators hypothesize that infertility patients undergoing IUI who receive female autologous platelet-rich plasma (PRP) co-incubation with husband's sperm would have higher clinical pregnancy rate.

Primary outcome:

To compare the incidence of clinical pregnancy outcome in those infertility patients undergoing IUI with female PRP co-incubation with husband's sperm group and non-PRP group.

Secondary outcomes:

* To evaluate the post-culture sperm parameters between the intervention group and control group * To evaluate the IUI parameter between the intervention group and control group * To evaluate the safeness between the female PRP co-incubation with husband's sperm in the IUI group and non-PRP group, including potential infection rate or other pregnancy outcomes such as miscarriage, multiple pregnancy, ectopic pregnancy and molar pregnancy

Eligibility criteria

Qualifiers

Patients who were eligible for IUI cycles in Assissted Reproduction Technolog unit, Prince of Wales Hospital

Female patients aged >18 years old and < 42 years old

BMI < 30 kg/m2

Disqualifiers

Concurrent administration of other agents such as prednisolone, intravenous immunoglobulin, or G-CSF

Administration of anticoagulants or NSAIDs at least 7 days before PRP infuse

Drug addiction

Untreated urinary tract infection

Trial design

Treatments tested in this trial

  • non-PRP group (control group)
  • PRP group (intervention group)

Treatment groups

288 Participants
are divided into 2 treatment groups